B+
Bull case
30%
Probability
Target price
$96.00
+15.9% vs current
MET
MetLifeBNYSE / Insurance
Last Price
At close
2026-06-02
AI scenario view
RankAlpha Sentiment CodexPost-earnings T+3Most likely
B
Base case
45%
Probability
Target price
$90.00
+8.7% vs current
B-
Bear case
25%
Probability
Target price
$72.00
-13.1% vs current
AI sentiment snapshot
Latest data as of 2026-05-09
Recent news sentiment (30D)
+18.4
Positive
Company
+23.6
Positive
Macro
+18.6
Positive
Pulse
-32.0
Negative
Sentiment proxy
+54.3
Score
AI commentary
Tone is mixed-positive. Primary company materials support a strong operating quarter and solid capital position, but checked post-print coverage emphasized an EPS beat paired with a revenue miss and a modest negative immediate stock reaction. Headline buzz is high because this is a T+3 earnings follow-up, but delayed analyst revision visibility was limited in checked sources, which keeps this as a cautious monitoring-style positive rather than a high-conviction upgrade.
RankAlpha Sentiment Codex - 2026-05-09
Open post-earnings memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2026-05-06event1Q26 earnings and capital return reset the near-term tapeMedium impact
MetLife's May 6 earnings package showed adjusted EPS up 23% to $2.42, adjusted earnings up 18% to $1.586B, adjusted PFOs excluding PRT up 10% to $13.3B, direct expense ratio at 11.9% versus the 12.1% full-year target, and over $1.1B returned via buybacks and dividends; this keeps the post-print debate centered on execution versus a revenue-miss narrative [#8-K-2026-05-06].
2026-05-20catalystT+3 estimate digestion after EPS beat but revenue missMedium impact
Checked post-print secondary coverage framed the quarter as an EPS beat versus consensus but with revenue below expectations and a modest negative immediate stock reaction, so the next 1-2 weeks matter for whether estimate revisions and target maintenance outweigh the top-line miss.
2026-08-05catalystExpense discipline, liquidity, and MIM scaling support medium-term reratingHigh impact
Management highlighted $3.9B of holding-company cash at the top of target range, 379% RBC versus a 360% target, MIM adjusted earnings up 68%, and AUM up 22% helped by PineBridge, while office and commercial mortgage exposures were shown as reduced versus year-end 2023; if these remain intact, MET can defend a higher multiple than a pure spread-and-mortality story [#8-K-2026-05-06][#10-Q-2026-05-07].
Recommendation
N/A
No formal recommendation provided.
As of 2026-05-09 • Updated nightlySource: Internal modelMethodology